GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE296nnn/GSE296076/primary200OKTranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296076GEOGSEfalseARP-1 wild-type and ARP-1 carfilzomib-resistant cells RNA-seq analysisProteasome inhibitors (PIs) such as carfilzomib (Cfz) are highly efficacious for patients with Multiple myeloma (MM). However, relapses and acquired resistance to PI treatment emerges in most patients. Here, we established Cfz-resistant MM cells. RNA-seq analysis revealed significant alterations in cholesterol- and lipid-related metabolic pathways in the resistant cells.2026/07/01GSE296076GSM8964726GSM8964725GSM8964728GSM896472716791296076Homo sapiens